🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer laws, risking penalties, legal action or prison.

Platform Reaction and Material Elimination

Based on the social media company, the service has taken down violative material and banned related keywords and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Information and Costs

Within these communities, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly significant medical dangers”.